Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression

NCT06098469 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire de Besancon as lead sponsor.

NCT NCT06098469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06098469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developping a a Brain-controlled Art App to Ease Residual Symptoms of Depression
Lead sponsor
Centre Hospitalier Universitaire de Besancon
Phase
Not applicable
Overall status
Unknown status
Start date
October 10, 2024
Completion date
February 28, 2025
Enrollment
22 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression